The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution

Thrombosis and Haemostasis

Volumn 101, Issue 1, 2009, Pages 165-170

  De Smedt, Erik ^a   Wagenvoord, Rob ^a   Hemker, H Coen ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fluorogenic methods; Sample dilution; Thrombin generation

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; CALCIUM; CITRIC ACID; PROCOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; DEXTRO PHENYLALANYLPIPECOLYLARGININE 4 NITROANILIDE; DIPEPTIDE; FLUORESCENT DYE; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; THROMBIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; THROMBIN TIME; BLOOD CLOTTING; BLOOD CLOTTING TEST; KINETICS; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD SPECIMEN COLLECTION; DIPEPTIDES; FACTOR IX; FACTOR VIII; FLUORESCENT DYES; HUMANS; KINETICS; LIPOPROTEINS; PROTEIN C; PROTEIN S; PROTHROMBIN; REPRODUCIBILITY OF RESULTS; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

EID: 60849131893     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-08-0523     Document Type: Article

References (18)

1. Lo K, Diamond SL. Blood coagulation kinetics: high throughput method for real-time reaction monitoring. Thromb Haemost 2004; 92: 874-882,
2. Hemker HC, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-253.
3. Tehaikovski SN, et al. Development of a calibrated automated thrombography based TG test in mouse plasma. J Thromb Haemost 2007; 5: 2079-2086.
4. Dusel CH, et al. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis 2004; 15: 405-411.
5. Grundman C, et al. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence. Thromb Haemost 2005; 94: 1338-1339.
6. Varadi K, et al. Monitoring the bioavailability of FEIBA with a TG assay. J Thromb Haemost 2003; 1: 2374-2380.
7. De Smedt E, et al. The technique of measuring TG with Androgenic substrates: 1. Necessity of adequate calibration. Thromb Haemost 2008; 100: 343-349.
8. Bajaj SP, et al. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
9. Thaler E, Schmer G. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods. Br J Haematol 1975; 31: 233-243.
10. Hendrix H, et al. Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem 1983; 258: 3637-3644.
11. Hemker HC, et al. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17.
12. Beguin S, et al. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity. Thromb Haemost 1992; 68: 136-142.
13. Wagenvoord R, et al. The limits of simulation of the clotting system, J Thromb Haemost 2006; 4: 1331-1338',
14. Heeb MJ, et al. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877.
15. Heeb MJ, et al. Protein S binds to and inhibits factor Xa, Proc Natl Acad Sei USA 1994; 91: 2728-2732.
16. Hackeng TM, et al. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 2006; 103: 3106-3111,
17. van Hylckama Vlieg A, et al. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. Br J Haematol 2007; 138: 769-774.
18. Besser M, et. al. High rate of unprovoked recurrent venous thrombosis is associated with a high thrombin generating potential in a prospective cohort study. J. Thromb, Haemost 2008; 6: 1720-1725.